Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators - ELATE

Description:

The goal of the ELATE trial was to evaluate if, after ≥3 months of conventional-intensity warfarin therapy, low-intensity warfarin would result in less bleeding and still prevent recurrent venous thromboembolism compared with conventional intensity in patients with unprovoked venous thromboembolism.